Medtronic Tells 10th Circ. Bone Device Suit Is Preempted

Law360, New York (February 10, 2014, 9:01 PM EST) -- The Tenth Circuit should affirm a dismissal of a failure-to-warn suit against Medtronic Inc. by a patient claiming the device maker promoted its bone fusion product for off-label uses because those claims are preempted by the Federal Food, Drug and Cosmetic Act, Medtronic told the court recently.

Oklahoma federal Judge Vicki Miles-LaGrange was correct to find that Section 360k (a) of the act — which the U.S. Supreme Court has found shields medical device makers if they have complied with federal law — preempts plaintiff Patricia...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Caplinger v. Medtronic, et al


Case Number

13-6061

Court

Appellate - 10th Circuit

Nature of Suit

4367 Torts

Date Filed

March 8, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.